Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin to prevent oral mucositis in adjuvant chemotherapy for colon cancer
2004-005007-14Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stomatitis and colon cancer comparing Palifermin with Placebo (2 arms). Primary endpoint: Incidence of grade ≥ 2 oral mucositis in cycle 1. Started Mar 2005; status: completed.
02
Drugs
palifermin
03
Conditions
stomatitiscolon cancer
Beyond the preview
Go deeper on 2004-005007-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005007-14.